JP2016512525A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512525A5
JP2016512525A5 JP2016501297A JP2016501297A JP2016512525A5 JP 2016512525 A5 JP2016512525 A5 JP 2016512525A5 JP 2016501297 A JP2016501297 A JP 2016501297A JP 2016501297 A JP2016501297 A JP 2016501297A JP 2016512525 A5 JP2016512525 A5 JP 2016512525A5
Authority
JP
Japan
Prior art keywords
seq
chain variable
region
represented
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016501297A
Other languages
English (en)
Japanese (ja)
Other versions
JP6525432B2 (ja
JP2016512525A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/023623 external-priority patent/WO2014159430A1/en
Publication of JP2016512525A publication Critical patent/JP2016512525A/ja
Publication of JP2016512525A5 publication Critical patent/JP2016512525A5/ja
Application granted granted Critical
Publication of JP6525432B2 publication Critical patent/JP6525432B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016501297A 2013-03-14 2014-03-11 抗rankl抗体および使用方法 Expired - Fee Related JP6525432B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786050P 2013-03-14 2013-03-14
US61/786,050 2013-03-14
PCT/US2014/023623 WO2014159430A1 (en) 2013-03-14 2014-03-11 Anti-rankl antibodies and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018142624A Division JP2018183176A (ja) 2013-03-14 2018-07-30 抗rankl抗体および使用方法

Publications (3)

Publication Number Publication Date
JP2016512525A JP2016512525A (ja) 2016-04-28
JP2016512525A5 true JP2016512525A5 (enExample) 2017-04-13
JP6525432B2 JP6525432B2 (ja) 2019-06-05

Family

ID=51625166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016501297A Expired - Fee Related JP6525432B2 (ja) 2013-03-14 2014-03-11 抗rankl抗体および使用方法
JP2018142624A Pending JP2018183176A (ja) 2013-03-14 2018-07-30 抗rankl抗体および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018142624A Pending JP2018183176A (ja) 2013-03-14 2018-07-30 抗rankl抗体および使用方法

Country Status (6)

Country Link
US (2) US10259878B2 (enExample)
EP (1) EP2970462A4 (enExample)
JP (2) JP6525432B2 (enExample)
CN (1) CN105189551B (enExample)
HK (1) HK1216754A1 (enExample)
WO (1) WO2014159430A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014159430A1 (en) 2013-03-14 2014-10-02 Apexigen, Inc. Anti-rankl antibodies and methods of use
EP3497393A4 (en) 2016-08-08 2020-03-18 Ticona LLC Thermally conductive polymer composition for a heat sink
MX2019004862A (es) 2016-10-28 2019-08-12 Lilly Co Eli Anticuerpos anti-rankl y usos de los mismos.
CN116041513A (zh) * 2017-10-27 2023-05-02 河北药明生物技术有限公司 靶向rankl的治疗性抗体
JP2022514215A (ja) * 2018-12-05 2022-02-10 ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ Rankアンタゴニストおよびその使用
TW202306990A (zh) * 2021-05-12 2023-02-16 大陸商江蘇恆瑞醫藥股份有限公司 特異性結合rankl和ngf的抗原結合分子及其醫藥用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5675063A (en) 1995-02-28 1997-10-07 Loyola University Of Chicago Immortalized rabbit hybridoma fusion partner
WO2002015846A2 (en) * 2000-08-21 2002-02-28 Smithkline Beecham Corporation Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
EP1432438A2 (en) * 2001-06-06 2004-06-30 Immunex Corporation Use of rank antagonists to treat cancer
US7462697B2 (en) 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
US7429487B2 (en) 2005-07-05 2008-09-30 Epitomics, Inc. Fusion partner for production of monoclonal rabbit antibodies
WO2008088594A2 (en) 2007-01-12 2008-07-24 Anaptysbio, Inc. Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species
CN101796072B (zh) * 2007-05-24 2014-09-24 埃博灵克斯股份有限公司 用于治疗骨疾病和病症的针对rank-l的氨基酸序列以及包括其的多肽
WO2011017294A1 (en) * 2009-08-07 2011-02-10 Schering Corporation Human anti-rankl antibodies
WO2014159430A1 (en) 2013-03-14 2014-10-02 Apexigen, Inc. Anti-rankl antibodies and methods of use
WO2015125922A1 (ja) 2014-02-20 2015-08-27 国立大学法人東京大学 抗rankl抗体

Similar Documents

Publication Publication Date Title
JP2014509510A5 (enExample)
TWI778943B (zh) 抗tigit抗原結合蛋白及其使用方法
JP2022177090A5 (enExample)
TWI828767B (zh) 抗hla-g抗體、包含抗hla-g抗體之組成物及使用抗hla-g抗體之方法
HRP20192346T1 (hr) Molekule anti-lag-3 antitijela i njihove uporabe
JP2017535257A5 (enExample)
RU2018102606A (ru) Молекулы, связывающиеся с psl pseudomonas, и пути их применения
JP2016507523A5 (enExample)
JP2018121657A5 (enExample)
JP2015533853A5 (enExample)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2016512525A5 (enExample)
JP2018520657A5 (enExample)
JP2014519334A5 (enExample)
JP2017052784A5 (enExample)
FI3487882T3 (fi) Gprc5d-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat gprc5d:tä ja cd3:a, sekä niiden käyttötapoja
JP2017505125A5 (enExample)
JP2015163068A5 (enExample)
HRP20200583T1 (hr) Protutijela koja neutraliziraju gp120 i njihova upotreba
JP2010526028A5 (enExample)
JP2018510617A5 (enExample)
JP6421371B2 (ja) トランスポーターに対する抗体およびその用途
JP2012254092A5 (enExample)
PE20231958A1 (es) Moleculas de union a pd-1 y metodos de uso de las mismas
RU2018108048A (ru) Новые анти-pd-1 антитела